Blogs about NSDQ - Stockpickr! Your Source for Stock Ideas

Blogs about NSDQ

Blogs	Description	Date Updated
China Sky One Nears Approval on Two Diagnostic Tests	China Sky One Medical (NSDQ: CSKI) said it expects to have final SFDA approval for two more diagnostic kits by the end of 2009. One is a diagnostic test for Human Prostate Specific Antigen, an indicator of prostate related diseases, and the other is a determination kit for Luteinizing Hormone, a diagnosis test for female sterility.The kits have completed their clinical trials, and they have now also passed examinations conducted by the Chinese National Institute for the Control of Pharmaceutical...	November 27, 2009
Sinovac Adds Vaccine Capacity by Forming JV	Sinovac Biotech (NSDQ: SVA) announced a new Joint Venture, Sinovac (Dalian) Vaccine Technology Co., Ltd., that will research, develop and produce human vaccines. Sinovac will contribute its vaccine expertise and capital, while Dalian Jin Gang Group will throw in land use rights, manufacturing facilities and established operating infrastructure. Representatives of Sinovac will fill the major operational posts in the JV.At the outset, Sinovac will contribute 60 million RMB ($8.8 million), which wi...	November 26, 2009
China Biotech Week in Review: CROs Consolidating	In late October, when PPD, Inc. (NSDQ: PPDI) acquired fellow CRO Excel PharmaStudies, we suggested more CRO consolidation might follow. However, it was both a surprise – and not a surprise – when the news broke that PPD would follow up its Excel transaction with another major CRO acquisition, BioDuro LLC (see story). The 660 employees of BioDuro, which is based in Beijing, focus on drug discovery. As Greg Scott, our Executive Editor, points out, the acquisition was interesting becaus...	November 22, 2009
PPD Continues Rapid China Growth with Another CRO Acquisition	PPD, Inc. (NSDQ: PPDI) is quickly building up its China-based CRO capability. The company announced it will acquire BioDuro LLC, a CRO based in Beijing whose 660 employees focus on drug discovery (pre-clinical) services. The acquisition complements PPD’s purchase of Excel PharmaStudies earlier this month. Excel is a clinical CRO that conducts Phase II through Phase IV clinical trials from its offices throughout China. PPD did not disclose financial details of either transaction.BioDuro has...	November 19, 2009
Sinovac’s Q3 Soars	Sinovac Biotech Ltd. (NSDQ: SVA) announced it has won a $3 million contract to supply its hepatitis A vaccine, Healive, to the Shanghai government. Sinovac said five companies vied for the contract, but Sinovac was chosen the sole supplier. Sinovac will supply Healive to Shanghai over the next twelve months. The order came as a result of expanded government purchase programs for vaccines, which are part of the national expanded immunization program (EPI) funded by the Chinese government....	November 17, 2009
Oculus Wins China Approval for Animal Wound Product	Oculus Innovative Sciences (NSDQ: OCLS) of California reported that its partners have received China regulatory approval to market its wound healing solution as an animal product. Based on the company’s Microcyn technology, Vetericyn products speed the healing of wounds while fighting infection. Bayer (BAYRY.PK) Animal Health secured the approvals in China and Taiwan.Oculus is currently negotiating distribution agreements with Bayer, involving both pricing and minimum purchases, for the tw...	November 17, 2009
BMP Sunstone Partners with Pfizer to Distribute Endometriosis Treatment in China	BMP Sunstone Corporation (NSDQ: BJGP) and Pfizer China (NYSE: PFE) have formed a strategic partnership to distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China. Endometriosis is a medical condition in women of childbearing age that can cause significant pain. Financial details of the agreement were not disclosed.The partnership is interesting because Pfizer has its own drug distribution network in China. But the big pharma deci...	November 11, 2009
China Medical Wins Approval for Leukemia FISH Probe	China Medical Technologies (NSDQ: CMED) received SFDA approval for its Leukemia BCR/ABL fusion gene detection FISH Probe. The probe uses DNA probes to detect Philadelphia translocation, a chromosomal abnormality associated with three forms of leukemia. Detecting Philadelphia translocation is a critical diagnosis and prognosis tool for selecting the different treatment protocols appropriate for chronic myelogenous leukemia, acute lymphoblastic leukemia and acute myelogenous leukemia. At this poin...	November 10, 2009
China Biotech Week in Review: Is CRO Consolidation a New Theme?	Is consolidation the new theme in China’s fragmented CRO sector? Over the past five to ten years, an almost bewildering array of new CROs has sprung into existence. Many of them have teamed up with others to provide a broader level of services. But last week, in a surprise announcement, PPD, Inc. (NSDQ: PPDI), a worldwide $2.6 billion CRO with headquarters in the US, announced it has reached an agreement to acquire Excel PharmaStudies (see story). Excel is a China-based CRO specializing in...	November 01, 2009
Insituform (INSU): Investing in sewer & pipe repair	Filed under: Newsletters, Commodities, Oil, Stocks to Buy, Green Stocks"For those in search of a pure play in the water infrastructure sector, my favorite bet is Insituform (NSDQ: INSU)," says Roger Conrad in his newly-launched advisory service, The New World. Conrad explains, "Its most innovative product is its fast-growing 'trenchless' repair service to aging and cracked pipes." Here's his review. "Rather than dig up and replace actual pipes, the process involves injecting a compound into th...	February 11, 2009

Enter search text here: